BRPI0912342A2 - tiazolidinonas, oxazolidinonas substituídas terapêuticas, e compostos relacionados - Google Patents
tiazolidinonas, oxazolidinonas substituídas terapêuticas, e compostos relacionadosInfo
- Publication number
- BRPI0912342A2 BRPI0912342A2 BRPI0912342A BRPI0912342A BRPI0912342A2 BR PI0912342 A2 BRPI0912342 A2 BR PI0912342A2 BR PI0912342 A BRPI0912342 A BR PI0912342A BR PI0912342 A BRPI0912342 A BR PI0912342A BR PI0912342 A2 BRPI0912342 A2 BR PI0912342A2
- Authority
- BR
- Brazil
- Prior art keywords
- thiazolidinones
- related compounds
- substituted oxazolidinones
- therapeutic substituted
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5181708P | 2008-05-09 | 2008-05-09 | |
| PCT/US2009/042930 WO2009137544A1 (en) | 2008-05-09 | 2009-05-06 | Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0912342A2 true BRPI0912342A2 (pt) | 2015-10-06 |
Family
ID=40726702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0912342A BRPI0912342A2 (pt) | 2008-05-09 | 2009-05-06 | tiazolidinonas, oxazolidinonas substituídas terapêuticas, e compostos relacionados |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7786117B2 (pt) |
| EP (1) | EP2285796A1 (pt) |
| JP (1) | JP2011520811A (pt) |
| KR (1) | KR20110017878A (pt) |
| CN (1) | CN102089295A (pt) |
| AU (1) | AU2009244325B2 (pt) |
| BR (1) | BRPI0912342A2 (pt) |
| CA (1) | CA2728229A1 (pt) |
| RU (1) | RU2010149494A (pt) |
| WO (1) | WO2009137544A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9540357B1 (en) | 2014-07-31 | 2017-01-10 | Allergan, Inc. | 15-aryl prostaglandins as EP4 agonists, and methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2915527A (en) | 1959-12-01 | Oxazolidone compounds and means for | ||
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4022794A (en) | 1976-05-24 | 1977-05-10 | Merck & Co., Inc. | Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| CH656877A5 (de) * | 1981-11-27 | 1986-07-31 | Erba Farmitalia | Optisch aktive oder racemische prostaglandinderivate. |
| JPH0692305B2 (ja) * | 1987-05-15 | 1994-11-16 | 株式会社上野製薬応用研究所 | 体温上昇剤 |
| JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
| US6437146B1 (en) | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| WO2003040126A1 (en) * | 2001-11-05 | 2003-05-15 | Allergan, Inc. | φ-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS |
| WO2006050459A2 (en) * | 2004-10-28 | 2006-05-11 | Cook Incorporated | Methods and systems for modifying vascular valves |
| US7659295B2 (en) * | 2006-08-23 | 2010-02-09 | Allergan, Inc. | Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| CA2676291C (en) * | 2007-01-31 | 2017-11-28 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
-
2009
- 2009-05-06 US US12/436,274 patent/US7786117B2/en not_active Expired - Fee Related
- 2009-05-06 AU AU2009244325A patent/AU2009244325B2/en not_active Expired - Fee Related
- 2009-05-06 CA CA2728229A patent/CA2728229A1/en not_active Abandoned
- 2009-05-06 WO PCT/US2009/042930 patent/WO2009137544A1/en active Application Filing
- 2009-05-06 EP EP09743530A patent/EP2285796A1/en not_active Withdrawn
- 2009-05-06 CN CN2009801268503A patent/CN102089295A/zh active Pending
- 2009-05-06 RU RU2010149494/04A patent/RU2010149494A/ru not_active Application Discontinuation
- 2009-05-06 JP JP2011508619A patent/JP2011520811A/ja active Pending
- 2009-05-06 BR BRPI0912342A patent/BRPI0912342A2/pt not_active IP Right Cessation
- 2009-05-06 KR KR1020107027696A patent/KR20110017878A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20090281171A1 (en) | 2009-11-12 |
| CA2728229A1 (en) | 2009-11-12 |
| KR20110017878A (ko) | 2011-02-22 |
| CN102089295A (zh) | 2011-06-08 |
| AU2009244325B2 (en) | 2014-09-25 |
| WO2009137544A1 (en) | 2009-11-12 |
| EP2285796A1 (en) | 2011-02-23 |
| RU2010149494A (ru) | 2012-06-20 |
| US7786117B2 (en) | 2010-08-31 |
| JP2011520811A (ja) | 2011-07-21 |
| AU2009244325A1 (en) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2018004I1 (el) | Συνδυαστικη θεραπεια υποκατεστημενης oξαζολιδινονης | |
| NL300891I2 (nl) | Lotilaner en zouten daarvan | |
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| BRPI0822722A2 (pt) | Implemento para cuidado oral. | |
| BRPI0906802A2 (pt) | Implemento para cuidado oral. | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| DK2134708T3 (da) | 3-Cyano-4-(4-tetrahydropyranphenyl)-pyridin-2-on-derivater | |
| BRPI0817537A2 (pt) | 4-[3-(4-ciclopropanocarbonil-piperazina-i-carboni-,-fl uoro-benzil]-2h-ftalazin-1-ona | |
| DK2144905T3 (da) | Terapeutiske midler | |
| DK2035369T3 (da) | Terapeutiske | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0915822A2 (pt) | dispositivo médico | |
| DK2173831T3 (da) | Brøndbehandling | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| DK2131818T3 (da) | Ny doseringsform | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| BRPI0914182A2 (pt) | composto, e, composição farmacêutica | |
| BRPI0909764A2 (pt) | compostos terapêuticos | |
| DK2346559T3 (da) | Medicinsk anordning | |
| BRPI0912193A2 (pt) | compostos terapêuticos. | |
| BRPI0906879A2 (pt) | Compostos terapêuticos | |
| DK2089708T3 (da) | Forudsigelige kræft-immunterapi parametre | |
| BRPI0912342A2 (pt) | tiazolidinonas, oxazolidinonas substituídas terapêuticas, e compostos relacionados | |
| FR2937843B1 (fr) | Paravent medical |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |